Jane Street Group, LLC Cocrystal Pharma, Inc. Transaction History

Jane Street Group, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 16, 2022	BUY	$0.38 - $0.55 $5,641 - $8,164	14,845 New	14,845 $6,000
Q1 2022 May 17, 2022	SELL	$0.48 - $0.71 $6,315 - $9,342	-13,158 Closed	0 $0
Q4 2021 Feb 15, 2022	BUY	$0.65 - $1.02 $1,344 - $2,110	2,069 Added 18.66%	13,158 $9,000
Q3 2021 Nov 16, 2021	BUY	$1.01 - $1.25 $11,199 - $13,861	11,089 New	11,089 $12,000
Q1 2021 May 18, 2021	SELL	$1.3 - $2.35 $15,046 - $27,198	-11,574 Closed	0 $0
Q4 2020 Feb 17, 2021	SELL	$0.8 - $2.16 $23,590 - $63,694	-29,488 Reduced 71.81%	11,574 $16,000
Q3 2020 Nov 17, 2020	BUY	$0.86 - $2.36 $35,313 - $96,906	41,062 New	41,062 $38,000
Q4 2019 Feb 14, 2020	SELL	$0.39 - $2.05 $4,204 - $22,101	-10,781 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$1.69 - $2.88 $158 - $270	-94 Reduced 0.86%	10,781 $22,000
Q2 2019 Aug 15, 2019	SELL	$2.06 - $2.75 $5,189 - $6,927	-2,519 Reduced 18.81%	10,875 $26,000
Q1 2019 May 16, 2019	SELL	$2.65 - $4.14 $3,747 - $5,853	-1,414 Reduced 9.55%	13,394 $37,000
Q4 2018 Feb 15, 2019	SELL	$1.6 - $3.68 $5,403 - $12,427	-3,377 Reduced 18.57%	14,808 $53,000
Q3 2018 Nov 14, 2018	SELL	$2.3 - $4.95 $7,495 - $16,132	-3,259 Reduced 15.2%	18,185 $45,000
Q2 2018 Aug 15, 2018	BUY	$1.79 - $6.25 $38,384 - $134,025	21,444 New	21,444 $78,000

Ticker COCP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,122,420
Market Cap $21.3M
Description
Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, and norovirus infections. The company ...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.